Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?

Poorly differentiated gastroenteropancreatic neuroendocrine carcinomas are aggressive neoplasms of challenging clinical management. A small proportion of patients with early-stage disease may achieve long-term survival, but the majority of patients present with rapidly lethal metastatic disease. Cur...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Carbonero, Rocio, Anton-Pascual, Beatriz, Modrego, Andrea, del Carmen Riesco-Martinez, Maria, Lens-Pardo, Alberto, Carretero-Puche, Carlos, Rubio-Cuesta, Beatriz, Soldevilla, Beatriz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335166/
https://www.ncbi.nlm.nih.gov/pubmed/36879384
http://dx.doi.org/10.1210/endrev/bnad006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335166/
https://www.ncbi.nlm.nih.gov/pubmed/36879384
http://dx.doi.org/10.1210/endrev/bnad006

Ejemplares similares